UnitedHealth Group Incorporated $UNH Shares Sold by Bridgeway Capital Management LLC

Key Points

• Bridgeway Capital Management LLC reduced its holdings in UnitedHealth Group by 5.6%, selling 2,163 shares and owning a total of 36,450 shares worth approximately $19.1 million.
• UnitedHealth Group reported an earnings per share (EPS) of $4.08 for the last quarter, which was below analysts' expectations of $4.45, while its quarterly revenue grew by 12.9% year-over-year.
• The company announced a quarterly dividend of $2.21 per share, set to be paid on September 23rd, resulting in an annualized dividend of $8.84 and a yield of 2.9%.

Bridgeway Capital Management LLC lowered its stake in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 5.6% in the 1st quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 36,450 shares of the healthcare conglomerate's stock after selling 2,163 shares during the quarter. Bridgeway Capital Management LLC's holdings in UnitedHealth Group were worth $19,091,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds have also bought and sold shares of the company. Bayforest Capital Ltd grew its position in UnitedHealth Group by 685.7% during the first quarter. Bayforest Capital Ltd now owns 55 shares of the healthcare conglomerate's stock valued at $29,000 after acquiring an additional 48 shares during the last quarter. Clal Insurance Enterprises Holdings Ltd raised its holdings in UnitedHealth Group by 416.7% during the 1st quarter. Clal Insurance Enterprises Holdings Ltd now owns 62 shares of the healthcare conglomerate's stock valued at $32,000 after buying an additional 50 shares during the last quarter. Copia Wealth Management bought a new stake in shares of UnitedHealth Group in the 4th quarter worth approximately $42,000. IAG Wealth Partners LLC bought a new position in UnitedHealth Group in the 1st quarter worth $42,000. Finally, Investment Management Corp VA ADV bought a new stake in shares of UnitedHealth Group during the 4th quarter valued at about $44,000. 87.86% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

Several equities analysts have commented on the company. Bank of America raised their price objective on UnitedHealth Group from $290.00 to $325.00 and gave the company a "neutral" rating in a research report on Monday, August 18th. Sanford C. Bernstein lifted their target price on shares of UnitedHealth Group from $337.00 to $379.00 and gave the company an "outperform" rating in a report on Friday. Morgan Stanley lowered their price objective on UnitedHealth Group from $342.00 to $325.00 and set an "overweight" rating for the company in a research note on Wednesday, August 20th. Wall Street Zen downgraded UnitedHealth Group from a "buy" rating to a "hold" rating in a report on Saturday, May 24th. Finally, JPMorgan Chase & Co. reduced their price objective on shares of UnitedHealth Group from $418.00 to $310.00 and set an "overweight" rating for the company in a research note on Wednesday, August 6th. Sixteen analysts have rated the stock with a Buy rating, six have given a Hold rating and three have issued a Sell rating to the stock. Based on data from MarketBeat, UnitedHealth Group has an average rating of "Moderate Buy" and an average target price of $354.86.

Insiders Place Their Bets

In related news, CEO Patrick Hugh Conway sold 589 shares of UnitedHealth Group stock in a transaction that occurred on Tuesday, June 10th. The shares were sold at an average price of $305.00, for a total value of $179,645.00. Following the completion of the sale, the chief executive officer directly owned 10,398 shares in the company, valued at $3,171,390. This trade represents a 5.36% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. 0.28% of the stock is currently owned by company insiders.

UnitedHealth Group Price Performance

UNH stock traded up $4.72 during mid-day trading on Friday, hitting $315.10. The company had a trading volume of 14,093,579 shares, compared to its average volume of 17,031,034. The company has a quick ratio of 0.85, a current ratio of 0.85 and a debt-to-equity ratio of 0.73. UnitedHealth Group Incorporated has a 12-month low of $234.60 and a 12-month high of $630.73. The company has a 50-day moving average price of $288.66 and a 200 day moving average price of $375.70. The company has a market capitalization of $285.38 billion, a price-to-earnings ratio of 13.65, a P/E/G ratio of 2.00 and a beta of 0.45.

UnitedHealth Group (NYSE:UNH - Get Free Report) last released its quarterly earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $4.45 by ($0.37). UnitedHealth Group had a net margin of 5.04% and a return on equity of 23.32%. The business had revenue of $111.62 billion for the quarter, compared to analysts' expectations of $111.75 billion. During the same period in the previous year, the company earned $6.80 EPS. UnitedHealth Group's revenue for the quarter was up 12.9% compared to the same quarter last year. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. On average, research analysts anticipate that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Tuesday, September 23rd. Stockholders of record on Monday, September 15th will be issued a $2.21 dividend. This represents a $8.84 dividend on an annualized basis and a dividend yield of 2.8%. The ex-dividend date is Monday, September 15th. UnitedHealth Group's dividend payout ratio (DPR) is currently 38.30%.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.